Martin Sumner-Smith

Current

• VP, Enterprise Architecture at Open Text

Past

• VP, Customer Partnership Programs at Open Text
• VP, Pharmaceutical & Life Sciences Solutions at Open Text
• President & CEO at Base4 Inc.

• Director, Research and others at Allelix Biopharmaceuticals Inc.

see less...

1 more...

Education

• Yale
• University of Toronto
• University of Guelph

1 more...

Connections

180 connections

Industry

Computer Software

Martin Sumner-Smith’s Summary

I was originally trained in molecular biology and gained experience in research management, technology assessment and business development in a biotechnology company. Subsequently I founded and found financing for two startups. I developed expertise in the application of knowledge management and content management systems (ECM) to pharmaceutical and other life sciences companies. I now work in a medium-sized software company in enterprise architecture.

Martin Sumner-Smith’s Experience

• VP, Enterprise Architecture

  Open Text

  (Public Company; 1001-5000 employees; OTEX; Computer Software industry)

  November 2007 — Present (11 months)

• VP, Customer Partnership Programs

  Open Text

  (Public Company; 1001-5000 employees; OTEX; Computer Software industry)

  June 2005 — October 2007 (2 years 5 months)

• VP, Pharmaceutical & Life Sciences Solutions

  Open Text

  (Public Company; 1001-5000 employees; OTEX; Computer Software industry)

  January 2001 — June 2005 (4 years 6 months)

  Global responsibility for strategy to address the pharmaceutical and life sciences markets for software products from Open Text - document management, knowledge management, regulatory compliance, clinical trial support, submission publishing, collaboration

• President & CEO

  Base4 Inc.

  (Privately Held; 11-50 employees; Pharmaceuticals industry)

  May 1996 — December 2000 (4 years 8 months)

  Originally started to provide bioinformatics services to biotechnology companies, Base4 was repositioned as the leading company providing project life-cycle solutions for pharmaceutical and biotechnology R&D. Clients for Base4’s PharMatrix solutions included multinational pharmaceutical companies and biotechnology companies of all sizes. Staff grew to 38 by mid-2000, with offices in the US, Canada and Switzerland.

• Director, Research and others

  Allelix Biopharmaceuticals Inc.

  (Public Company; 51-200 employees; AXB; Pharmaceuticals industry)

  July 1984 — April 1996 (11 years 10 months)